Castle Biosciences CSTL Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's operating lease right-of-use assets in other assets?
- Castle Biosciences (CSTL) reported operating lease right-of-use assets in other assets of $14.42M in Q1 2026.
- How has Castle Biosciences's operating lease right-of-use assets in other assets changed year-over-year?
- Castle Biosciences's operating lease right-of-use assets in other assets increased by 29.2% year-over-year, from $11.16M to $14.42M.